Ligand validation:6ZGP

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZGP_EPE_E_404	13%	24%	0.254	0.791	1.22	1.88	1	5	1	0	100%	1
6ZGP_EPE_A_404	10%	32%	0.292	0.794	1.01	1.66	1	5	0	0	100%	1
6ZGP_EPE_I_404	4%	32%	0.366	0.76	1.03	1.63	1	5	0	0	100%	1
6ZGP_EPE_C_404	4%	26%	0.377	0.771	1.36	1.61	1	2	0	0	100%	1
6ZGP_EPE_K_404	4%	30%	0.347	0.719	1.3	1.48	1	3	0	0	100%	1
6ZGP_EPE_H_404	3%	23%	0.429	0.762	1.4	1.79	1	3	0	0	100%	1
6ZGP_EPE_B_404	2%	31%	0.435	0.719	1.18	1.54	1	6	1	0	100%	1
6ZGP_EPE_L_404	2%	31%	0.467	0.735	1.06	1.65	1	4	2	0	100%	1
6ZGP_EPE_F_404	2%	23%	0.445	0.71	1.23	1.91	1	6	2	0	100%	1
6ZGP_EPE_G_404	2%	24%	0.386	0.632	1.28	1.79	1	5	1	0	100%	1
6ZGP_EPE_J_404	2%	28%	0.456	0.693	1.25	1.65	1	5	0	0	100%	1
6ZGP_EPE_D_404	1%	34%	0.467	0.648	1.2	1.41	1	4	0	0	100%	1
6Y9D_EPE_A_405	4%	16%	0.257	0.634	2.28	1.41	1	3	0	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	31%	0.063	0.987	0.79	1.91	1	5	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.